mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo

Mechanisms of Development

Volumn 120, Issue 9, 2003, Pages 1021-1032

  Dodou, Evdokia ^a   Xu, Shan Mei ^a   Black, Brian L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; E box; Enhancer; MEF2C; Mouse; Muscle; MyoD; Myogenic bHLH; Transcription; Transgenic

Indexed keywords

HELIX LOOP HELIX PROTEIN; MYOCYTE ENHANCER FACTOR 2C; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CELL DIFFERENTIATION; CONTROLLED STUDY; E BOX ELEMENT; EMBRYO; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MALE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

EID: 0141449169     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(03)00178-3     Document Type: Article

References (53)

1. Amacher S.L., Buskin J.N., Hauschka S.D. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell Biol. 13:1993;2753-2764.
2. Andres V., Cervera M., Mahdavi V. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J. Biol. Chem. 270:1995;23246-23249.
3. Arnold H.H., Braun T. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. Int. J. Dev. Biol. 40:1996;345-353.
4. Arnold H.H., Winter B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8:1998;539-544.
5. Beason K.B., Acuff C.G., Steinhelper M.E., Elton T.S. An A/T-rich cis-element is essential for rat angiotensin II type 1A receptor transcription in vascular smooth muscle cells. Biochim. Biophys. Acta. 1444:1999;25-34.
6. Bergstrom D.A., Penn B.H., Strand A., Perry R.L., Rudnicki M.A., Tapscott S.J. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell. 9:2002;587-600.
7. Bi W., Drake C.J., Schwarz J.J. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 211:1999;255-267.
8. Black B.L., Olson E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:1998;167-196.
9. Black B.L., Martin J.F., Olson E.N. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. Biol. Chem. 270:1995;2889-2892.
10. Black B.L., Molkentin J.D., Olson E.N. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell Biol. 18:1998;69-77.
11. Bour B.A., O'Brien M.A., Lockwood W.L., Goldstein E.S., Bodmer R., Taghert P.H., Abmayr S.M., Nguyen H.T. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9:1995;730-741.
12. Brennan T.J., Olson E.N. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev. 4:1990;582-595.
13. Buskin J.N., Hauschka S.D. Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell Biol. 9:1989;2627-2640.
14. Cheng T.C., Hanley T.A., Mudd J., Merlie J.P., Olson E.N. Mapping of myogenin transcription during embryogenesis using transgenes linked to the myogenin control region. J. Cell Biol. 119:1992;1649-1656.
15. Cheng T.C., Wallace M.C., Merlie J.P., Olson E.N. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science. 261:1993;215-218.
16. Cripps R.M., Black B.L., Zhao B., Lien C.L., Schulz R.A., Olson E.N. The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes Dev. 12:1998;422-434.
17. Cserjesi P., Olson E.N. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol. Cell Biol. 11:1991;4854-4862.
18. Dodou E., Sparrow D.B., Mohun T., Treisman R. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells. Nucleic Acids Res. 23:1995;4267-4274.
19. Edmondson D.G., Cheng T.C., Cserjesi P., Chakraborty T., Olson E.N. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell Biol. 12:1992;3665-3677.
20. Edmondson D.G., Lyons G.E., Martin J.F., Olson E.N. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 120:1994;1251-1263.
21. Fickett J.W. Coordinate positioning of MEF2 and myogenin binding sites. Gene. 172:1996;GC19-GC32.
22. Ghatpande S., Goswami S., Mathew S., Rong G., Cai L., Shafiq S., Siddiqui M.A. Identification of a novel cardiac lineage-associated protein(cCLP-1): A candidate regulator of cardiogenesis. Dev. Biol. 208:1999;210-221.
23. Gossett L.A., Kelvin D.J., Sternberg E.A., Olson E.N. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell Biol. 9:1989;5022-5033.
24. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the Mouse Embryo. 1994;Cold Spring Harbor Laboratory Press, Plainview, NY.
25. Horton R.M. In vitro recombination and mutagenesis of DNA: SOEing together tailor-made genes. White B.A. PCR Cloning Protocols. vol. 67:1997;141-149 Humana Press, Totowa, NJ.
26. Kothary R., Clapoff S., Darling S., Perry M.D., Moran L.A., Rossant J. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development. 105:1989;707-714.
27. Leifer D., Krainc D., Yu Y.T., McDermott J., Breitbart R.E., Heng J., Neve R.L., Kosofsky B., Nadal-Ginard B., Lipton S.A. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl. Acad. Sci. USA. 90:1993;1546-1550.
28. Leifer D., Golden J., Kowall N.W. Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience. 63:1994;1067-1079.
29. Lilly B., Zhao B., Ranganayakulu G., Paterson B.M., Schulz R.A., Olson E.N. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science. 267:1995;688-693.
30. Lin Q., Schwarz J., Bucana C., Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 276:1997;1404-1407.
31. Lin Q., Lu J., Yanagisawa H., Webb R., Lyons G.E., Richardson J.A., Olson E.N. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 125:1998;4565-4574.
32. Lyons G.E., Micales B.K., Schwarz J., Martin J.F., Olson E.N. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15:1995;5727-5738.
33. Megeney L.A., Rudnicki M.A. Determination versus differentiation and the MyoD family of transcription factors. Biochem. Cell Biol. 73:1995;723-732.
34. Molkentin J.D., Olson E.N. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA. 93:1996;9366-9373.
35. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1995;1125-1136.
36. Naidu P.S., Ludolph D.C., To R.Q., Hinterberger T.J., Konieczny S.F. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol. Cell Biol. 15:1995;2707-2718.
37. Olson E.N. MyoD family: a paradigm for development? Genes Dev. 4:1990;1454-1461.
38. Olson E.N., Klein W.H. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1994;1-8.
39. Ornatsky O.I., Andreucci J.J., McDermott J.C. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272:1997;33271-33278.
40. Pin C.L., Ludolph D.C., Cooper S.T., Klocke B.J., Merlie J.P., Konieczny S.F. Distal regulatory elements control MRF4 gene expression in early and late myogenic cell populations. Dev. Dyn. 208:1997;299-312.
41. Ranganayakulu G., Zhao B., Dokidis A., Molkentin J.D., Olson E.N., Schulz R.A. A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 171:1995;169-181.
42. Ridgeway A.G., Wilton S., Skerjanc I.S. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275:2000;41-46.
43. Spitz F., Demignon J., Porteu A., Kahn A., Concordet J.P., Daegelen D., Maire P. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Proc. Natl. Acad. Sci., USA. 95:1998;14220-14225.
44. Swanson B.J., Jack H.M., Lyons G.E. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. Mol. Immunol. 35:1998;445-458.
45. Wang D.Z., Valdez M.R., McAnally J., Richardson J., Olson E.N. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development. 128:2001;4623-4633.
46. Weintraub H. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell. 75:1993;1241-1244.
47. Wong M.W., Pisegna M., Lu M.F., Leibham D., Perry M. Activation of Xenopus MyoD transcription by members of the MEF2 protein family. Dev. Biol. 166:1994;683-695.
48. Wright W.E., Binder M., Funk W. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell Biol. 11:1991;4104-4110.
49. Yang X.W., Model P., Heintz N. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat. Biotechnol. 15:1997;859-865.
50. Yee S.P., Rigby P.W. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7:1993;1277-1289.
51. Yun K., Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8:1996;877-889.
52. Zhou M.D., Goswami S.K., Martin M.E., Siddiqui M.A. A new serum-responsive, cardiac tissue-specific transcription factor that recognizes the MEF-2 site in the myosin light chain-2 promoter. Mol. Cell Biol. 13:1993;1222-1231.
53. Zhu H., Nguyen V.T., Brown A.B., Pourhosseini A., Garcia A.V., van Bilsen M., Chien K.R. A novel, tissue-restricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b/MEF-2) in the rat myosin light-chain 2 gene. Mol. Cell Biol. 13:1993;4432-4444.